Crosspoint Capital Strategies, LLC - CHINA BIOLOGIC PRODS INC ownership

Quarter-by-quarter ownership
Crosspoint Capital Strategies, LLC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2015$10,000
+42.9%
90
+25.0%
0.00%0.0%
Q1 2015$7,000
+40.0%
72
+4.3%
0.00%
+50.0%
Q4 2014$5,000690.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2024
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 287,277$35,760,00028.32%
WARBURG PINCUS LLC 6,674$830,780,00013.45%
Ariose Capital Management Ltd 238,841$27,689,0007.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 12,600$1,568,0004.48%
RUDMAN ERROL M 37,001$4,606,0003.72%
INDUS CAPITAL PARTNERS, LLC 245,237$30,527,0002.89%
Ativo Capital Management LLC 93,784$11,674,0002.70%
OBERWEIS ASSET MANAGEMENT INC/ 63,305$7,880,0002.27%
Point72 Hong Kong Ltd 31,500$3,921,0002.14%
Cormorant Asset Management, LP 112,867$14,050,0001.55%
View complete list of CHINA BIOLOGIC PRODS INC shareholders